✉ Email this page to a colleague
« Back to Dashboard
REL-1017 is an investigational drug.
There have been 8 clinical trials for REL-1017. The most recent clinical trial was a Phase 2 trial, which was initiated on March 30th 2021.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Relmada Therapeutics, Inc., Clinical Trial Unit Ente Ospedaliero Cantonale, and Mauro Manconi.
There are six hundred and thirty-seven US patents protecting this investigational drug and twelve international patents.
Recent Clinical Trials for REL-1017
|A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)||Relmada Therapeutics, Inc.||Phase 3|
|Open Label Study to Assess the Safety of REL-1017 for Major Depressive Disorder||Relmada Therapeutics, Inc.||Phase 3|
|A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)||Relmada Therapeutics, Inc.||Phase 3|
Top disease conditions for REL-1017
Top clinical trial sponsors for REL-1017
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|REL-1017||⤷ Try a Trial||Therapeutic approaches for treating Parkinson's disease||Pharnext (Issy les Moulineaux, FR)||⤷ Try a Trial|
|REL-1017||⤷ Try a Trial||Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer||Capella Therapeutics, Inc. (San Diego, CA)||⤷ Try a Trial|
|REL-1017||⤷ Try a Trial||Inhalable pharmaceutical compositions||iCeutica Pty Ltd. (Iluka, WA, AU)||⤷ Try a Trial|
|REL-1017||⤷ Try a Trial||Powder filling processes||Adamis Pharmaceuticals Corporation (San Diego, CA)||⤷ Try a Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|REL-1017||Australia||AU2012222348||2031-03-01||⤷ Try a Trial|
|REL-1017||Australia||AU2012222351||2031-03-01||⤷ Try a Trial|
|REL-1017||Australia||AU2013224959||2031-03-01||⤷ Try a Trial|
|REL-1017||Australia||AU2013224960||2031-03-01||⤷ Try a Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|